Table 1: Biology

Biologic

Frequency
Percent
Valid Percent
Cumulative Percent

Valid
Etanercept
1
10.0
10.0
10.0

Infliximab
9
90.0
90.0
100.0

Total
10
100.0
100.0

Table 2: Diagnosis

Diagnosis

Frequency
Percent
Valid Percent
Cumulative Percent

Valid
IBD
3
30.0
30.0
30.0

Psoriatric Arthritis
1
10.0
10.0
40.0

RA
4
40.0
40.0
80.0

Reactive Arthritis
2
20.0
20.0
100.0

Total
10
100.0
100.0

Table 3: Tobacco

Tobacco

Frequency
Percent
Valid Percent
Cumulative Percent

Valid
C
3
30.0
30.0
30.0

F
4
40.0
40.0
70.0

N
3
30.0
30.0
100.0

Total
10
100.0
100.0

Table 4: Descriptive Statistics

Descriptives

Statistic
Std. Error

Age
Mean
38.5000
2.61300

95% Confidence Interval for Mean
Lower Bound
32.5890

Upper Bound
44.4110

Std. Deviation
8.26304

Range
23.00

Figure 1: Boxplot (Age)
Answer 1: According to table 4 shows that the mean age of the sample data is 38.50.
Answer 2: According to table 3 shows that the 30% of patients never used tobacco.
Answer 3: According to table 4 shows that the standard deviation for age is 8.26.
Answer 4: According to figure 1 show that there are outliers is case of male respondents with respect to gender between minimum 28 and median 43.
Answer 5: According to table 4 shows that the range of age values is 23.
Answer 6: According to table 1, 90% of patients had been taking Infliximab.
Answer 7: According to table 2 shows that 40% of patients had rheumatoid arthritis as their primary diagnosis
Answer 8: According to table 2 shows that 30% of patients had irritable bowel syndrome as their primary diagnosis.
Answer 9: According to table 4 shows that the 95% CI for age is 32.59 < Age < 44.41 Answer 10: According to table 2 shows that the 10% of patients had psoriatic arthritis as their primary diagnosis.